Let’s take Infectious Disease Testing to the Next Level

Microbial infections and antibiotic resistance can affect anybody, amounting to more than 15 Mio annual cases globally.

scroll down arrow

Microbial infections and antibiotic resistance can affect anybody, amounting to more than 15 Mio annual cases globally.

Decoding Infections

At Ares Genetics, we are working towards revolutionizing infectious disease diagnostics and therapeutics by artificial intelligence based DNA testing to improve patient outcomes at reduced costs.

Decoding Infections

At Ares Genetics, we are working towards revolutionizing infectious disease diagnostics and therapeutics by artificial intelligence based DNA testing to improve patient outcomes at reduced costs.

Our Vision

Conquering emerging antibiotic resistance, one of the biggest 21st century health threats and improving outcomes for patients with severe infections.

Our Mission

Revolutionizing infectious disease diagnostics and therapeutics by translating success stories from next-generation diagnostics and  precision medicine to microbial infections.

Vision & Mission

Leadership

Dr. Andreas E. Posch

Managing Director & CEO

Dr. Andreas E. Posch, Managing Director and CEO, joined from Siemens, where he developed Ares Genetics’ technology core and was responsible for Bioinformatics R&D at Siemens Healthcare as well as Software Sensors & Analytics with Siemens Corporate Technology.

read more

Dr. Achim Plum

Managing Director

Dr. Achim Plum, Managing Director, has more than 18 years of management experience in the diagnostics industry with a focus on innovative molecular diagnostics, biomarker development, and personalized medicine.

read more

Dr. Stephan Beisken

Head of Bioinformatics & Analytics

Dr. Stephan Beisken, Head of Bioinformatics & Analytics, joined from Discuva Limited, an antibiotic drug discovery company, where he was heading the Bioinformatics group.

read more

Since its incorporation in March 2017, ARES has established an international team of highly committed business and technology experts with proven innovation & commercialization track-record.

Together, and supported by our global partner network, we are working towards revolutionizing infectious disease diagnostics and therapeutics.

Our Global Network

Commercial & Development Partners

curetis-logosaarland-university-logoHIPS-logomfpl-logoBGI-logoMGI-logo

ARESdb Contributors

ARESdb builds on the GEnetic Antibiotic Resistance and Susceptibility Database (GEAR) and associated assets that the Curetis Group acquired from Siemens in late 2016.

Since its incorporation in March 2017, Ares Genetics has continuously expanded ARESdb with various development partners from academia and industry.

SIEMENS-Healthineers-logo

Supported by

FFG-logoWirschtaftsAgenturWien-logoWKO-logovienna-biocenter-logoEU-logo